Search

Your search keyword '"Koivisto, Anne"' showing total 587 results

Search Constraints

Start Over You searched for: Author "Koivisto, Anne" Remove constraint Author: "Koivisto, Anne"
587 results on '"Koivisto, Anne"'

Search Results

2. Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa

6. Emissions from modern engines induce distinct effects in human olfactory mucosa cells, depending on fuel and aftertreatment

7. Early Alzheimer’s disease pathology in human cortex involves transient cell states

8. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

9. Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients

10. New insights into the genetic etiology of Alzheimer’s disease and related dementias

13. Corrigendum to “A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery” [J. Drug Deliv. Sci. Technol. 93 (March 2024), 105419]

15. Deep learning assisted quantitative analysis of Aβ and microglia in patients with idiopathic normal pressure hydrocephalus in relation to cognitive outcome

18. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

21. Utility of the INECO Frontal Screening and the Frontal Assessment Battery in detecting executive dysfunction in early-onset cognitive impairment and dementia.

22. Different Trajectories of Depressive Symptoms in Alzheimer's Disease Caregivers – 5-Year Follow-Up.

25. Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus

26. Diabetes is associated with familial idiopathic normal pressure hydrocephalus: a case–control comparison with family members

27. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

28. Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH

30. Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration

36. 7th Kuopio Conference 2022. Session 3. Anne Koivisto and Johanna Vesterinen: AIRUT Project - Interface and management for ISO 18626 based Interlibrary loans of National Repository Library of Finland [Präsentation als PDF]

39. An Alzheimer’s Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition

41. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

43. A study protocol for AI-Mind: Artificial intelligence combined with neurophysiological and neuropsychological measures for dementia prediction

45. An Alzheimer’s disease patient-derived olfactory cell model identifies gene expression changes associated with cognition

46. Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

48. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

49. Development of Lyophilised Eudragit ® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration.

Catalog

Books, media, physical & digital resources